11/21/2013 05:41 PM
Training Topic: Why Pharmacovigilance (Phase IV) Trials are Increasingly Seen: Why they are Important and what they tell us?
Instructor: Dr Charles H Pierce
There is no one-size-fits-all guidance to help a particular drug or drug class prepare for the studies. There are, however Guidance documents for “Risk Minimization Action Plans” and “Good Pharmacovigilance Practices and “Pharmacoepidemiologic Assessment” and there is also the ICH E2E Guidance of Pharmacovigilance Planning. The likelihood of Data Monitoring Committees being required is also expected to increase.
There are a number of points that are only seen in Phase IV (PV) studies and why these are important in the Drug Development process will be covered. These studies (and there are several types of Phase IV/Post Marketing studies) answer important safety questions and because of this and the duration of these studies, they are almost always associated with Data Monitoring Committees (DMC’s).
Why Should you Attend:
With the increasing complexity of therapeutic agents – now involving more “biologics” – and an increase of use of new agents beyond the original intention and testing, it is essential to know as early as possible any untoward and unexpected Adverse Events and other serious toxicities. The well known examples of Drugs pulled from the market after approval attest to the need for Phase IV (Post marketing approval) studies.
Objectives of the Presentation:
- What are the types of Phase IV studies
- The Nature of the I/E criteria in Phase IV studies
- How does the Safety Monitoring Plan differ in Phase IV
- What constitutes a “rare” adverse event?
- Why large studies are needed to uncover rare Serious Adverse Events
- What is the role and value of a DMC in large studies
- What endpoints is the FDA looking for once they have approved a drug/device
Who can Benefit:
Those benefiting the most would be the Principal Investigators and sub investigators, Clinical Research Scientists (PKs, Biostatisticians,), Safety Nurses, Clinical Research Associates (CRAs) and Coordinators (CRCs), Recruiting staff, QA / QC auditors and staff, & Clinical Research Data managers In addition, the holders of the IND for new products i.e. the Sponsors will benefit.
Live Session - How it works
- We will send Username and password 24 hours prior to webinar at your email address.
- Webinar presentation handouts will be shared in pdf format, a day before live presentation.
- Use the login details to participate in sessions.
- Clear out your queries through interactive Q&A chat boxes with the speaker.
- We need to know your experience, so please don't skip to provide us with your overall presentation feedback.
- Get certification of attendance.
Recorded Session - How it works
- Once you purchase a webinar you will receive username and password at your email address.
- Use the login details to view recorded webinars.
- Presentation handouts will also be shared in pdf format.
- Access to the recording is valid only till 6 months starting from the date of purchase.
- Get certification of attendance.